News and Events

The GEC-ESTRO Phase III trial validates the oncologic concept of APBI. The results of the GEC-ESTRO phase III trial comparing APBI versus WBI are significant and potentially practice changing in that they indicate for the first time (in a large, well-designed, contemporary phase III trial with adequate follow-up) that the scientific concept of treating only the lumpectomy cavity (plus a proper margin) is just as effective and safe as treating the whole breast in selected patients with early stage breast cancer.

For decades, electron IORT has been used for locally advanced and recurrent cancers, achieving excellent clinical results in both local control and survival, especially in indications where it is often difficult to obtain clear surgical margins such as pancreatic cancer, colorectal cancers, head and neck cancers, GYN cancers, and sarcomas. The National Comprehensive Cancer Network (NCCN)http://www.nccn.org has recommended IORT with electrons as the treatment of choice for locally advanced and recurrent rectal cancer.

IORT – Smaller, mobile delivery systems and new clinical evidence are driving this innovative form of radiation therapy, which can significantly reduce the associated burdens of treatment for patients.

In patients with locally recurrent extremity soft tissue sarcoma, limb-salvage therapy with intraoperative radiation therapy (IORT) can deliver focal therapy and achieve local control for patients who otherwise may need more radical surgical procedures, according to a study by investigators at the University of California, San Francisco.

Respected “Radiation Oncology” publication reports on use of electron based intraoperative radiation therapy using the Mobetron® from IntraOp in inaugural study of APBI in Asian countries